In order to investigate whether the increased expression of MED15 is a response to androgen deprivation, we performed immunohistochemistry (IHC) for MED15 on hormone-naïve local recurrent PCa tissue before and local recurrent castration-resistant PCa after androgen deprivation therapy (ADT) from the same patients. This evidence concerns the gene MED15 and posterior cortical atrophy.